Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 870 participants.
Also called NCT01340768
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 870 participants
- Sponsor
- Registry
-
NCT01340768 -
CTRI/2011/06/001838
-
- Other papers using this trial's data
- Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01340768. Randomized; no masking; primary purpose treatment. Start 2010-06-22 (actual); primary completion 2011-09-21 (actual). Results posted on 2012-10-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Sitagliptin
- Intervention (Drug)
- Sulfonylurea
- Intervention (Drug)
- Metformin
- Lead sponsor
- Merck Sharp & Dohme LLC
Record details
- Record id
cardio:ct-nct01340768- Content hash
d31afdc272894bc5193c73f9258b40726da9ef86219b8efebeab0a2436ccece1